ACADIA Pharmaceuticals Inc. Profile Avatar - Palmy Investing

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the tr…
Biotechnology
US, San Diego [HQ]

Balance Sheet

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
49.00 38.00 32.00 108.00 189.00 325.00 221.00 561.00 384.00 540.00 783.00 782.00 700.00 587.00 748.00
Current
48.00 37.00 31.00 108.00 188.00 324.00 218.00 547.00 373.00 526.00 760.00 717.00 617.00 507.00 616.00
Non Current
1.00 - - - - - - - - - - 2.00 13.00 11.00 14.00 22.00 65.00 82.00 79.00 132.00
Liabilities
37.00 8.00 8.00 23.00 6.00 15.00 22.00 42.00 49.00 61.00 84.00 155.00 159.00 187.00 317.00
Current
14.00 5.00 6.00 5.00 6.00 15.00 21.00 42.00 49.00 59.00 74.00 105.00 96.00 125.00 254.00
Non Current
22.00 2.00 2.00 17.00 - - - - - - - - - - 1.00 9.00 49.00 63.00 61.00 62.00
Equity
12.00 29.00 23.00 84.00 182.00 309.00 199.00 518.00 335.00 479.00 699.00 627.00 540.00 400.00 431.00
Stockholders' Equity
12.00 29.00 23.00 84.00 182.00 309.00 199.00 518.00 335.00 479.00 699.00 627.00 540.00 400.00 431.00
Retained Earnings
-339.00 -324.00 -346.00 -367.00 -405.00 -498.00 -662.00 -933.00 -1,223.00 -1,468.00 -1,704.00 -1,985.00 -2,153.00 -2,369.00 -2,430.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Preferred Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Profit
-45.00 15.00 -22.00 -20.00 -37.00 -92.00 -164.00 -271.00 -289.00 -245.00 -235.00 -281.00 -167.00 -215.00 -61.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
350.00 353.00 370.00 452.00 587.00 807.00 862.00 1,452.00 1,559.00 1,948.00 2,402.00 2,612.00 2,694.00 2,770.00 2,862.00
Loss Other Compr. Income
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
End of ACAD's Analysis
CIK: 1070494 CUSIP: 004225108 ISIN: US0042251084 LEI: - UEI: -
Secondary Listings
ACAD has no secondary listings inside our databases.